Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Kammertöns, Thomas Dr. (7) Kopp, Joachim Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (2) Leutz, Achim Prof. Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (11) Nguyen, Tam Hoai Dr. (1) Pezzutto, Antonio Prof. Dr. (4) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (11) Uckert, Wolfgang Prof. Dr. (6) Willimsky, Gerald Dr. (8) Wollert-Wulf, Brigitte (2) (-) Blankenstein, Thomas Prof. Dr. (26) (-) Daniel, Peter Prof. Dr. (2) (-) Janz, Martin Dr. (9) (-) Biologie maligner Lymphome (9) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (26) Translationale Onkologie solider Tumore (2) Translationale Tumorimmunologie (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (3) 2000 (9) 2001 (5) 2002 (6) 2003 (12) (-) 2004 (10) (-) 2005 (12) (-) 2006 (5) 2007 (7) 2008 (7) 2009 (5) (-) 2010 (8) 2011 (9) 2012 (8) 2013 (13) 2014 (5) 2015 (6) 2016 (5) 2017 (9) 2018 (5) 2019 (6) 2020 (4) 2021 (9) 2022 (10) 2023 (10) 2024 (3) 35 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Janz, Martin Dr.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie 2004200520062010 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. September 2010 / Eur J Immunol Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo S. Shalapour K. Deiser O. Sercan J. Tuckermann K. Minnich G. Willimsky T. Blankenstein G.J. Haemmerling B. Arnold T. Schueler 01. September 2010 / Nat Med Transgenic mice with a diverse human T cell antigen receptor repertoire L.P. Li J.C. Lampert X. Chen C. Leitao J. Popovic W. Mueller T. Blankenstein 16. Dezember 2010 / Oncogene The immune response to sporadic colorectal cancer in a novel mouse model M. Czeh C. Loddenkemper S. Shalapour C. Schoen S. Robine E. Goldscheid H. Stein T. Schueler G. Willimsky T. Blankenstein 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. August 2004 / Immunity CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions L. Ohl M. Mohaupt N. Czeloth G. Hintzen Z. Kiafard J. Zwirner T. Blankenstein G. Henning R. Foerster 01. Juli 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein 01. Januar 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch 01. Januar 2005 / Int J Cancer Tumor-induced antibodies resemble the response to tissue damage S. Preiss T. Kammertoens C. Lampert G. Willimsky T. Blankenstein 01. Januar 2005 / Curr Opin Immunol The role of tumor stroma in the interaction between tumor and immune system T. Blankenstein Seitennummerierung Erste Seite « First Vorherige Seite ‹ Previous Seite 1 Aktuelle Seite 2 Seite 3 Seite 4 Nächste Seite Next › Letzte Seite Last »
01. September 2010 / Eur J Immunol Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo S. Shalapour K. Deiser O. Sercan J. Tuckermann K. Minnich G. Willimsky T. Blankenstein G.J. Haemmerling B. Arnold T. Schueler
01. September 2010 / Nat Med Transgenic mice with a diverse human T cell antigen receptor repertoire L.P. Li J.C. Lampert X. Chen C. Leitao J. Popovic W. Mueller T. Blankenstein
16. Dezember 2010 / Oncogene The immune response to sporadic colorectal cancer in a novel mouse model M. Czeh C. Loddenkemper S. Shalapour C. Schoen S. Robine E. Goldscheid H. Stein T. Schueler G. Willimsky T. Blankenstein
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. August 2004 / Immunity CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions L. Ohl M. Mohaupt N. Czeloth G. Hintzen Z. Kiafard J. Zwirner T. Blankenstein G. Henning R. Foerster
01. Juli 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein
01. Januar 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch
01. Januar 2005 / Int J Cancer Tumor-induced antibodies resemble the response to tissue damage S. Preiss T. Kammertoens C. Lampert G. Willimsky T. Blankenstein
01. Januar 2005 / Curr Opin Immunol The role of tumor stroma in the interaction between tumor and immune system T. Blankenstein